Array Bridge is testing promising drug candidates that can effectively bind and even degrade target proteins, but not via their active sites.

A new study published in Biochemistry sheds light on how bacteria regulate their genes, challenging long-held assumptions about protein behavior. The research compares how two bacterial species ...

The full abstract can be accessed at the AD/PD online interactive program. The AD/PD™ Conference is an annual event attracting leading medical and scientific professionals from around the world ...

G Protein-Coupled Receptors (GPCRs) in advancing GPCR-targeted therapies, including the use of agonists, antagonists, biased ...

Congruence Therapeutics, a computationally-driven biotechnology company building a unique pipeline of correctors for diseases of protein misfolding, including MC4R-deficient genetic obesity, ...